.rll-youtube-player .play{--wpr-bg-376754f0-7b3b-4e1c-962a-8ba2c5daa047: url('https://catchingnews.com/wp-content/plugins/wp-rocket/assets/img/youtube.png');}.perfmatters-lazy-youtube .play{--wpr-bg-5979fc18-191b-4180-8b7e-ee14e0c62942: url('https://catchingnews.com/wp-content/plugins/perfmatters/img/youtube.svg');}

Tag: SNDX Stock

Equity Investing

Here’s the Reason Why Syndax Pharmaceuticals, Inc. Stock Lost 11% in the After Market

Syndax Pharmaceuticals, Inc. (SNDX) is a biopharmaceutical company developing innovative pipeline therapies for cancer patients. One of the candidate products of the company is SNDX-5613

Catching News are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.

Tag: SNDX Stock

Here’s the Reason Why Syndax Pharmaceuticals, Inc. Stock Lost 11% in the After Market

Popular Articles

Mars Mission Boosts Rocket Lab (RKLB) Stock Performance

Aldeyra (ALDX) Stock Climbs Substantially After Positive Clinical Trial Outcome

Surge In Above Food (ABVE) Stock After Announcing Strategic Acquisition

Important Links